Neurotech wins license to develop Amgen's CNTF

March 1, 2002

Paris - Neurotech S.A. will exclusively develop and market Amgen Inc.'s ciliary neurotrophic factor (CNTF), a protein that has protective effects in animals with retinitis pigmentosa.